Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
    • CME
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CCR Focus Archive
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Breast Cancer
      • Clinical Trials
      • Immunotherapy: Facts and Hopes
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Clinical Cancer Research
Clinical Cancer Research
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
    • CME
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CCR Focus Archive
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Breast Cancer
      • Clinical Trials
      • Immunotherapy: Facts and Hopes
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Table of Contents

Editorial

  • Editorial
    Immunogenic Targets in Non–Small Cell Lung Cancer: More Is More
    Sacha Gnjatic
    Clin Cancer Res August 1 2005 11 (15) 5331-5332; DOI:10.1158/1078-0432.CCR-05-0880

The Biology Behind

  • The Biology Behind
    Getting to the Surface: A Link Between Tumor Antigen Discovery and Natural Presentation of Peptide-MHC Complexes
    Carolyn E. Clark and Robert H. Vonderheide
    Clin Cancer Res August 1 2005 11 (15) 5333-5336; DOI:10.1158/1078-0432.CCR-05-1057

Perspectives

  • Perspectives
    Maintenance Therapy to Suppress Micrometastasis: The New Challenge for Adjuvant Cancer Treatment
    Richard J. Epstein
    Clin Cancer Res August 1 2005 11 (15) 5337-5341; DOI:10.1158/1078-0432.CCR-05-0437

  • Perspectives
    New Paradigm in Dose-Finding Trials: Patient-Specific Dosing and Beyond Phase I
    André Rogatko, James S. Babb, Mourad Tighiouart, Fadlo R. Khuri and Gary Hudes
    Clin Cancer Res August 1 2005 11 (15) 5342-5346; DOI:10.1158/1078-0432.CCR-05-0458

Human Cancer Biology

  • Human Cancer Biology
    Multiple Mechanisms of Telomere Maintenance Exist in Liposarcomas
    Jay E. Johnson, Robert J. Varkonyi, Jaclyn Schwalm, Ryan Cragle, Andres Klein-Szanto, Arthur Patchefsky, Edna Cukierman, Margaret von Mehren and Dominique Broccoli
    Clin Cancer Res August 1 2005 11 (15) 5347-5355; DOI:10.1158/1078-0432.CCR-05-0684

  • Human Cancer Biology
    S100P Promotes Pancreatic Cancer Growth, Survival, and Invasion
    Thiruvengadam Arumugam, Diane M. Simeone, Kenneth Van Golen and Craig D. Logsdon
    Clin Cancer Res August 1 2005 11 (15) 5356-5364; DOI:10.1158/1078-0432.CCR-05-0092

  • Human Cancer Biology
    Promoter Hypermethylation Profile of Ovarian Epithelial Neoplasms
    Prakash B. Makarla, M. Hossein Saboorian, Raheela Ashfaq, Kiyomi O. Toyooka, Shinichi Toyooka, John D. Minna, Adi F. Gazdar and John O. Schorge
    Clin Cancer Res August 1 2005 11 (15) 5365-5369; DOI:10.1158/1078-0432.CCR-04-2455

  • Human Cancer Biology
    Vitamin D3 Metabolism in Human Glioblastoma Multiforme: Functionality of CYP27B1 Splice Variants, Metabolism of Calcidiol, and Effect of Calcitriol
    Britta Diesel, Jens Radermacher, Matthias Bureik, Rita Bernhardt, Markus Seifert, Jörg Reichrath, Ulrike Fischer and Eckart Meese
    Clin Cancer Res August 1 2005 11 (15) 5370-5380; DOI:10.1158/1078-0432.CCR-04-1968

  • Human Cancer Biology
    Voltage-Gated Sodium Channel Expression and Potentiation of Human Breast Cancer Metastasis
    Scott P. Fraser, James K.J. Diss, Athina-Myrto Chioni, Maria E. Mycielska, Huiyan Pan, Rezan F. Yamaci, Filippo Pani, Zuzanna Siwy, Monika Krasowska, Zbigniew Grzywna, William J. Brackenbury, Dimis Theodorou, Meral Koyutürk, Handan Kaya, Esra Battaloglu, Manuela Tamburo De Bella, Martin J. Slade, Robert Tolhurst, Carlo Palmieri, Jie Jiang, David S. Latchman, R. Charles Coombes and Mustafa B.A. Djamgoz
    Clin Cancer Res August 1 2005 11 (15) 5381-5389; DOI:10.1158/1078-0432.CCR-05-0327

  • Human Cancer Biology
    The Matrix Metalloproteinase-9/Neutrophil Gelatinase-Associated Lipocalin Complex Plays a Role in Breast Tumor Growth and Is Present in the Urine of Breast Cancer Patients
    Cecilia A. Fernández, Li Yan, Gwendolyn Louis, Jiang Yang, Jeffery L. Kutok and Marsha A. Moses
    Clin Cancer Res August 1 2005 11 (15) 5390-5395; DOI:10.1158/1078-0432.CCR-04-2391

  • Human Cancer Biology
    Angiogenesis in the Bone Marrow of Patients with Breast Cancer
    Mariana Chavez-MacGregor, Alejandro Aviles-Salas, Dan Green, Adolfo Fuentes-Alburo, Celedonio Gómez-Ruiz and Alvaro Aguayo
    Clin Cancer Res August 1 2005 11 (15) 5396-5400; DOI:10.1158/1078-0432.CCR-04-2420

  • Human Cancer Biology
    Characterization of a Recurrent Germ Line Mutation of the E-Cadherin Gene: Implications for Genetic Testing and Clinical Management
    Gianpaolo Suriano, Sandie Yew, Paulo Ferreira, Janine Senz, Pardeep Kaurah, James M. Ford, Teri A. Longacre, Jeffrey A. Norton, Nicki Chun, Sean Young, Maria J. Oliveira, Barbara MacGillivray, Arundhati Rao, Dawn Sears, Charles E. Jackson, Jeff Boyd, Cindy Yee, Carolyn Deters, G. Shashidhar Pai, Lyn S. Hammond, Bobbi J. McGivern, Diane Medgyesy, Denise Sartz, Banu Arun, Brant K. Oelschlager, Mellisa P. Upton, Whitney Neufeld-Kaiser, Orlando E. Silva, Talia R. Donenberg, David A. Kooby, Shobha Sharma, Björn-Anders Jonsson, Henrik Gronberg, Steve Gallinger, Raquel Seruca, Henry Lynch and David G. Huntsman
    Clin Cancer Res August 1 2005 11 (15) 5401-5409; DOI:10.1158/1078-0432.CCR-05-0247

  • Human Cancer Biology
    Promoter Hypermethylation Is the Predominant Mechanism in hMLH1 and hMSH2 Deregulation and Is a Poor Prognostic Factor in Nonsmoking Lung Cancer
    Han-Shui Hsu, Chiao-Kai Wen, Yen-An Tang, Ruo-Kai Lin, Wing-Yin Li, Wen-Hu Hsu and Yi-Ching Wang
    Clin Cancer Res August 1 2005 11 (15) 5410-5416; DOI:10.1158/1078-0432.CCR-05-0601

Imaging, Diagnosis, Prognosis

  • Imaging, Diagnosis, Prognosis
    Surfactant Protein A Gene Deletion and Prognostics for Patients with Stage I Non–Small Cell Lung Cancer
    Feng Jiang, Nancy P. Caraway, Benjamin Nebiyou Bekele, Hua-Zhong Zhang, Abha Khanna, Huijun Wang, Ruiyun Li, Ricardo L. Fernandez, Tanweer M. Zaidi, Dennis A. Johnston and Ruth L. Katz
    Clin Cancer Res August 1 2005 11 (15) 5417-5424; DOI:10.1158/1078-0432.CCR-04-2087

  • Imaging, Diagnosis, Prognosis
    Detection of Melanoma Cells Displaying Multiple Genomic Changes in Histopathologically Negative Sentinel Lymph Nodes
    Anja Ulmer, Jörg R. Fischer, Stefan Schanz, Karl Sotlar, Helmut Breuninger, Klaus Dietz, Gerhard Fierlbeck and Christoph A. Klein
    Clin Cancer Res August 1 2005 11 (15) 5425-5432; DOI:10.1158/1078-0432.CCR-04-1995

  • Imaging, Diagnosis, Prognosis
    Functional Polymorphisms of Matrix Metalloproteinase-9 Are Associated with Risk of Occurrence and Metastasis of Lung Cancer
    Zhibin Hu, Xiang Huo, Daru Lu, Ji Qian, Jiannong Zhou, Yijiang Chen, Lin Xu, Hongxia Ma, Jingfu Zhu, Qingyi Wei and Hongbing Shen
    Clin Cancer Res August 1 2005 11 (15) 5433-5439; DOI:10.1158/1078-0432.CCR-05-0311

  • Imaging, Diagnosis, Prognosis
    A Predictive Model of Rectal Tumor Response to Preoperative Radiotherapy Using Classification and Regression Tree Methods
    Inti Zlobec, Russell Steele, Nilima Nigam and Carolyn C. Compton
    Clin Cancer Res August 1 2005 11 (15) 5440-5443; DOI:10.1158/1078-0432.CCR-04-2587

  • Imaging, Diagnosis, Prognosis
    FGFR3 and Tp53 Mutations in T1G3 Transitional Bladder Carcinomas: Independent Distribution and Lack of Association with Prognosis
    Silvia Hernández, Elena López-Knowles, Josep Lloreta, Manolis Kogevinas, Roberto Jaramillo, Alex Amorós, Adonina Tardón, Reina García-Closas, Consol Serra, Alfredo Carrato, Núria Malats and Francisco X. Real
    Clin Cancer Res August 1 2005 11 (15) 5444-5450; DOI:10.1158/1078-0432.CCR-05-0122

  • Imaging, Diagnosis, Prognosis
    Analysis of Apoptosis Protein Expression in Early-Stage Colorectal Cancer Suggests Opportunities for New Prognostic Biomarkers
    Maryla Krajewska, Hoguen Kim, Chul Kim, Haeyoun Kang, Kate Welsh, Shu-ichi Matsuzawa, Michelle Tsukamoto, Ronald G. Thomas, Nuria Assa-Munt, Zhe Piao, Koichi Suzuki, Manuel Perucho, Stan Krajewski and John C. Reed
    Clin Cancer Res August 1 2005 11 (15) 5451-5461; DOI:10.1158/1078-0432.CCR-05-0094

  • Imaging, Diagnosis, Prognosis
    Tumor-Associated Alterations in Caspase-14 Expression in Epithelial Malignancies
    Maryla Krajewska, Hoguen Kim, Eunah Shin, Susan Kennedy, Michael J. Duffy, Yick F. Wong, David Marr, Jowita Mikolajczyk, Ahmed Shabaik, Ivo Meinhold-Heerlein, Xianshu Huang, Steven Banares, Hirad Hedayat, John C. Reed and Stan Krajewski
    Clin Cancer Res August 1 2005 11 (15) 5462-5471; DOI:10.1158/1078-0432.CCR-04-2527

Cancer Therapy: Clinical

  • Cancer Therapy: Clinical
    Safety and Pharmacokinetics of the Dual Action Raf Kinase and Vascular Endothelial Growth Factor Receptor Inhibitor, BAY 43-9006, in Patients with Advanced, Refractory Solid Tumors
    Jeffrey W. Clark, Joseph P. Eder, David Ryan, Chetan Lathia and Heinz-Josef Lenz
    Clin Cancer Res August 1 2005 11 (15) 5472-5480; DOI:10.1158/1078-0432.CCR-04-2658

  • Cancer Therapy: Clinical
    Expression of Class III β-Tubulin Is Predictive of Patient Outcome in Patients with Non–Small Cell Lung Cancer Receiving Vinorelbine-Based Chemotherapy
    Pascal Sève, Sylvie Isaac, Olivier Trédan, Pierre-Jean Souquet, Yves Pachéco, Maurice Pérol, Laurence Lafanéchère, Aurélie Penet, Eva-Laure Peiller and Charles Dumontet
    Clin Cancer Res August 1 2005 11 (15) 5481-5486; DOI:10.1158/1078-0432.CCR-05-0285

  • Cancer Therapy: Clinical
    Phase I Study of OSI-7904L, a Novel Liposomal Thymidylate Synthase Inhibitor in Patients with Refractory Solid Tumors
    Gernot Beutel, Hilary Glen, Patrick Schöffski, Jon Chick, Stan Gill, James Cassidy and Chris Twelves
    Clin Cancer Res August 1 2005 11 (15) 5487-5495; DOI:10.1158/1078-0432.CCR-05-0104

  • Cancer Therapy: Clinical
    XAGE-1 Expression in Non–Small Cell Lung Cancer and Antibody Response in Patients
    Kazuhiko Nakagawa, Yuji Noguchi, Akiko Uenaka, Shuichiro Sato, Hideo Okumura, Motoyuki Tanaka, Michihide Shimono, Ali Mohamed Ali Eldib, Toshiro Ono, Nobuya Ohara, Tadashi Yoshino, Kazuki Yamashita, Tsukasa Tsunoda, Motoi Aoe, Nobuyoshi Shimizu and Eiichi Nakayama
    Clin Cancer Res August 1 2005 11 (15) 5496-5503; DOI:10.1158/1078-0432.CCR-05-0216

  • Cancer Therapy: Clinical
    A Multicenter Phase II Trial of Thalidomide and Celecoxib for Patients with Relapsed and Refractory Multiple Myeloma
    H Miles Prince, Linda Mileshkin, Andrew Roberts, Vinod Ganju, Craig Underhill, John Catalano, Richard Bell, John F. Seymour, David Westerman, Paul J. Simmons, Kate Lillie, Alvin D. Milner, Juliana Di Iulio, Jerome B. Zeldis and Robert Ramsay
    Clin Cancer Res August 1 2005 11 (15) 5504-5514; DOI:10.1158/1078-0432.CCR-05-0213

  • Cancer Therapy: Clinical
    Dendritic Cell Vaccination in Glioblastoma Patients Induces Systemic and Intracranial T-cell Responses Modulated by the Local Central Nervous System Tumor Microenvironment
    Linda M. Liau, Robert M. Prins, Sylvia M. Kiertscher, Sylvia K. Odesa, Thomas J. Kremen, Adrian J. Giovannone, Jia-Wei Lin, Dennis J. Chute, Paul S. Mischel, Timothy F. Cloughesy and Michael D. Roth
    Clin Cancer Res August 1 2005 11 (15) 5515-5525; DOI:10.1158/1078-0432.CCR-05-0464

  • Cancer Therapy: Clinical
    A Phase II Trial with Pharmacodynamic Endpoints of the Proteasome Inhibitor Bortezomib in Patients with Metastatic Colorectal Cancer
    Helen Mackay, David Hedley, Pierre Major, Carol Townsley, Mary Mackenzie, Mark Vincent, Pam Degendorfer, Ming-Sound Tsao, Trudey Nicklee, Diana Birle, John Wright, Lillian Siu, Malcolm Moore and Amit Oza
    Clin Cancer Res August 1 2005 11 (15) 5526-5533; DOI:10.1158/1078-0432.CCR-05-0081

  • Cancer Therapy: Clinical
    Pilot Study of Concurrent Etoposide and Cisplatin Plus Accelerated Hyperfractionated Thoracic Radiotherapy Followed by Irinotecan and Cisplatin for Limited-Stage Small Cell Lung Cancer: Japan Clinical Oncology Group 9903
    Kaoru Kubota, Yutaka Nishiwaki, Takahiko Sugiura, Kazumasa Noda, Kiyoshi Mori, Masaaki Kawahara, Shunichi Negoro, Koshiro Watanabe, Fumio Imamura, Tomohide Tamura and Nagahiro Saijo
    Clin Cancer Res August 1 2005 11 (15) 5534-5538; DOI:10.1158/1078-0432.CCR-04-1771

  • Cancer Therapy: Clinical
    Phase II Study of Gefitinib in Patients with Relapsed or Persistent Ovarian or Primary Peritoneal Carcinoma and Evaluation of Epidermal Growth Factor Receptor Mutations and Immunohistochemical Expression: A Gynecologic Oncology Group Study
    Russell J. Schilder, Michael W. Sill, Xiaowei Chen, Kathleen M. Darcy, Steven L. Decesare, George Lewandowski, Roger B. Lee, Cletus A. Arciero, Hong Wu and Andrew K. Godwin
    Clin Cancer Res August 1 2005 11 (15) 5539-5548; DOI:10.1158/1078-0432.CCR-05-0462

Cancer Therapy: Preclinical

  • Cancer Therapy: Preclinical
    Receptors for Luteinizing Hormone Releasing Hormone Expressed on Human Renal Cell Carcinomas Can Be Used for Targeted Chemotherapy with Cytotoxic Luteinizing Hormone Releasing Hormone Analogues
    Gunhild Keller, Andrew V. Schally, Timo Gaiser, Attila Nagy, Benjamin Baker, Gabor Halmos and Jörg B. Engel
    Clin Cancer Res August 1 2005 11 (15) 5549-5557; DOI:10.1158/1078-0432.CCR-04-2464

  • Cancer Therapy: Preclinical
    Prediction of Active Drug Plasma Concentrations Achieved in Cancer Patients by Pharmacodynamic Biomarkers Identified from the Geo Human Colon Carcinoma Xenograft Model
    Feng R. Luo, Zheng Yang, Huijin Dong, Amy Camuso, Kelly McGlinchey, Krista Fager, Christine Flefleh, David Kan, Ivan Inigo, Stephen Castaneda, Tai W. Wong, Robert A. Kramer, Robert Wild and Francis Y. Lee
    Clin Cancer Res August 1 2005 11 (15) 5558-5565; DOI:10.1158/1078-0432.CCR-05-0368

  • Cancer Therapy: Preclinical
    Induction of CD4+ and CD8+ T-Cell Responses to the Human Stromal Antigen, Fibroblast Activation Protein: Implication for Cancer Immunotherapy
    Martin Fassnacht, Jaewoo Lee, Caterina Milazzo, David Boczkowski, Zhen Su, Smita Nair and Eli Gilboa
    Clin Cancer Res August 1 2005 11 (15) 5566-5571; DOI:10.1158/1078-0432.CCR-05-0699

  • Cancer Therapy: Preclinical
    Chemopreventive and Therapeutic Efficacy of Orally Active Tyrosine Kinase Inhibitors in a Transgenic Mouse Model of Gallbladder Carcinoma
    Kaoru Kiguchi, Lynnsie Ruffino, Toru Kawamoto, Tetsuo Ajiki and John DiGiovanni
    Clin Cancer Res August 1 2005 11 (15) 5572-5580; DOI:10.1158/1078-0432.CCR-04-2603

  • Cancer Therapy: Preclinical
    Determination of Cellularly Processed HLA-A2402-Restricted Novel CTL Epitopes Derived from Two Cancer Germ Line Genes, MAGE-A4 and SAGE
    Yoshihiro Miyahara, Hiroaki Naota, Lijie Wang, Atsunori Hiasa, Megumi Goto, Masato Watanabe, Shigehisa Kitano, Satoshi Okumura, Tetsushi Takemitsu, Atsushi Yuta, Yuichi Majima, François A. Lemonnier, Thierry Boon and Hiroshi Shiku
    Clin Cancer Res August 1 2005 11 (15) 5581-5589; DOI:10.1158/1078-0432.CCR-04-2585

  • Cancer Therapy: Preclinical
    Prevention of Cancer Cachexia by a Novel Nuclear Factor κB Inhibitor in Prostate Cancer
    Kenji Kuroda, Yutaka Horiguchi, Jun Nakashima, Eiji Kikuchi, Kent Kanao, Akira Miyajima, Takashi Ohigashi, Kazuo Umezawa and Masaru Murai
    Clin Cancer Res August 1 2005 11 (15) 5590-5594; DOI:10.1158/1078-0432.CCR-04-2561

  • Cancer Therapy: Preclinical
    VEGI-192, a New Isoform of TNFSF15, Specifically Eliminates Tumor Vascular Endothelial Cells and Suppresses Tumor Growth
    Wen Hou, Dan Medynski, Shirley Wu, Xinli Lin and Lu-Yuan Li
    Clin Cancer Res August 1 2005 11 (15) 5595-5602; DOI:10.1158/1078-0432.CCR-05-0384

  • Cancer Therapy: Preclinical
    Induction of Higher-Avidity Human CTLs by Vector-Mediated Enhanced Costimulation of Antigen-Presenting Cells
    Sixun Yang, Kwong-Yok Tsang and Jeffrey Schlom
    Clin Cancer Res August 1 2005 11 (15) 5603-5615; DOI:10.1158/1078-0432.CCR-05-0670

  • Cancer Therapy: Preclinical
    Melanoma Therapy via Peptide-Targeted α-Radiation
    Yubin Miao, Mark Hylarides, Darrell R. Fisher, Tiffani Shelton, Herbert Moore, Dennis W. Wester, Alan R. Fritzberg, Christopher T. Winkelmann, Timothy Hoffman and Thomas P. Quinn
    Clin Cancer Res August 1 2005 11 (15) 5616-5621; DOI:10.1158/1078-0432.CCR-05-0619

  • Cancer Therapy: Preclinical
    Antiangiogenic Treatment with Three Thrombospondin-1 Type 1 Repeats versus Gemcitabine in an Orthotopic Human Pancreatic Cancer Model
    Xuefeng Zhang, Eric Galardi, Mark Duquette, Jack Lawler and Sareh Parangi
    Clin Cancer Res August 1 2005 11 (15) 5622-5630; DOI:10.1158/1078-0432.CCR-05-0459

  • Cancer Therapy: Preclinical
    Hsp90 Inhibitor 17-Allylamino-17-Demethoxygeldanamycin Prevents Synovial Sarcoma Proliferation via Apoptosis in In vitro Models
    Jefferson Terry, Joanna M. Lubieniecka, Wanda Kwan, Suzanne Liu and Torsten O. Nielsen
    Clin Cancer Res August 1 2005 11 (15) 5631-5638; DOI:10.1158/1078-0432.CCR-05-0398

  • Cancer Therapy: Preclinical
    Cooperative Antitumor Effect of Multitargeted Kinase Inhibitor ZD6474 and Ionizing Radiation in Glioblastoma
    Vincenzo Damiano, Davide Melisi, Cataldo Bianco, David Raben, Rosa Caputo, Gabriella Fontanini, Roberto Bianco, Anderson Ryan, A. Raffaele Bianco, Sabino De Placido, Fortunato Ciardiello and Giampaolo Tortora
    Clin Cancer Res August 1 2005 11 (15) 5639-5644; DOI:10.1158/1078-0432.CCR-05-0174

  • Cancer Therapy: Preclinical
    Roxithromycin Inhibits Constitutive Activation of Nuclear Factor κB by Diminishing Oxidative Stress in a Rat Model of Hepatocellular Carcinoma
    Shinichi Ueno, Dai Aoki, Fumitake Kubo, Kiyokazu Hiwatashi, Kenji Matsushita, Tohru Oyama, Ikuro Maruyama and Takashi Aikou
    Clin Cancer Res August 1 2005 11 (15) 5645-5650; DOI:10.1158/1078-0432.CCR-05-0652

Cancer Prevention

  • Cancer Prevention
    The Chemopreventive Agent Resveratrol Stimulates Cyclic AMP–Dependent Chloride Secretion In vitro
    Irina Blumenstein, Benjamin Keserü, Freya Wolter and Jürgen Stein
    Clin Cancer Res August 1 2005 11 (15) 5651-5656; DOI:10.1158/1078-0432.CCR-04-2674

Letters to the Editor

  • Letters to the Editor
    Longtime Recirculating Tumor Cells in Breast Cancer Patients
    Katharina Pachmann
    Clin Cancer Res August 1 2005 11 (15) 5657-5658; DOI:10.1158/1078-0432.CCR-05-0191

Corrections

  • Corrections
    Correction: Article on Chronic Lymphocytic Leukemia
    Clin Cancer Res August 1 2005 11 (15) 5659-5659; DOI:10.1158/1078-0432.CCR-11-15-COR

  • Corrections
    Correction: Article on In vitro Effects of the BH3 Mimetic, (−)-Gossypol, on Head and Neck Squamous Cell Carcinoma Cells
    Clin Cancer Res August 1 2005 11 (15) 5659-5659; DOI:10.1158/1078-0432.CCR-11-15-CORA

  • Corrections
    Correction: Article on Risk Assessment in Patients with Acute Myeloid Leukemia and a Normal Karyotype
    Clin Cancer Res August 1 2005 11 (15) 5659-5659; DOI:10.1158/1078-0432.CCR-11-15-CORB

Back to top
PreviousNext
Clinical Cancer Research: 11 (15)
August 2005
Volume 11, Issue 15
  • Table of Contents
  • About the Cover

Sign up for alerts

Issue Highlights

  • Prediction of Active Drug Plasma Concentrations Achieved in Cancer Patients by Pharmacodynamic Biomarkers Identified from the Geo Human Colon Carcinoma Xenograft Model
  • Multiple Mechanisms of Telomere Maintenance Exist in Liposarcomas
  • Receptors for Luteinizing Hormone Releasing Hormone Expressed on Human Renal Cell Carcinomas Can Be Used for Targeted Chemotherapy with Cytotoxic Luteinizing Hormone Releasing Hormone Analogues

Jump to

  • Editorial
  • The Biology Behind
  • Perspectives
  • Human Cancer Biology
  • Imaging, Diagnosis, Prognosis
  • Cancer Therapy: Clinical
  • Cancer Therapy: Preclinical
  • Cancer Prevention
  • Letters to the Editor
  • Corrections
Advertisement
  • Most Cited
  • Most Read
Loading
  • Immune Checkpoint Blockade Requires Macrophage CXCL9/CXCL10
  • PDAC and GATA6 Expression
  • Characterization of Glioblastoma Patient-Derived Xenografts
  • Guadecitabine and Carboplatin in Ovarian Cancer
  • Toxicity Management Affects Checkpoint Inhibitor Efficacy
More...
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • CCR Focus Archive
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Clinical Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Clinical Cancer Research
eISSN: 1557-3265
ISSN: 1078-0432

Advertisement